Hub : Traits :

Number of operations (self-reported)

20 significantly associated models · 7 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	3	49244657	50620043	1	1	1.8e-07	8.2e-07	0.2170	94	MST1R
2	4	105598022	107092169	1	2	4.2e-10	4.5e-12	0.0046	83	PPA2
3	7	2032803	3510741	1	1	5.1e-08	8.0e-08	0.0115	78	AMZ1
4	10	21087485	22484312	1	2	6.8e-09	3.9e-08	0.0363	86	CASC10
5	11	29646947	31048683	1	1	1.7e-09	2.1e-08	0.1450	93	ARL14EP
6	22	30034994	30675923	1	1	2.1e-08	1.9e-05	0.5460	98	MTMR3
7	22	50085456	51219006	1	1	1.5e-07	1.5e-05	0.0230	72	PPP6R2

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Weight	8.67	5	4	8.9	0.94	0.0045	AMZ1 ARL14EP CASC10 MST1R PPA2
Sitting height	8.64	4	2	4.4	0.59	0.2969	AMZ1 CASC10 MTMR3 PPA2
Height	8.60	4	3	6.7	0.62	0.2653	AMZ1 CASC10 MTMR3 PPA2
Standing height	8.57	3	2	4.4	0.68	0.3248	AMZ1 MTMR3 PPA2
Basal metabolic rate	8.36	5	3	6.7	0.91	0.0050	AMZ1 ARL14EP CASC10 MST1R PPA2
Leg fat-free mass (left)	8.35	5	3	6.7	0.89	0.0073	AMZ1 ARL14EP CASC10 MST1R PPA2
Leg predicted mass (left)	8.31	5	3	6.7	0.89	0.0075	AMZ1 ARL14EP CASC10 MST1R PPA2
Qualifications: College or University degree	8.22	3	2	4.4	-0.38	0.6169	CASC10 MST1R PPA2
Whole body fat-free mass	7.99	5	3	6.7	0.89	0.0077	AMZ1 ARL14EP CASC10 MST1R PPA2
Whole body water mass	7.95	5	3	6.7	0.89	0.0070	AMZ1 ARL14EP CASC10 MST1R PPA2
Arm predicted mass (left)	7.91	5	4	8.9	0.94	0.0017	AMZ1 ARL14EP CASC10 MST1R PPA2
Arm predicted mass (right)	7.90	5	4	8.9	0.94	0.0019	AMZ1 ARL14EP CASC10 MST1R PPA2
Arm fat-free mass (left)	7.81	5	4	8.9	0.94	0.0015	AMZ1 ARL14EP CASC10 MST1R PPA2
Leg fat-free mass (right)	7.73	5	3	6.7	0.87	0.0116	AMZ1 ARL14EP CASC10 MST1R PPA2
Leg predicted mass (right)	7.73	5	3	6.7	0.87	0.0114	AMZ1 ARL14EP CASC10 MST1R PPA2
Had major operations	7.65	3	0	0.0	0.94	0.0578	AMZ1 CASC10 MST1R
Arm fat-free mass (right)	7.59	5	4	8.9	0.93	0.0020	AMZ1 ARL14EP CASC10 MST1R PPA2
Leg fat mass (right)	7.59	4	4	8.9	0.97	0.0060	AMZ1 ARL14EP CASC10 MST1R
Hip circumference	7.48	5	3	6.7	0.97	0.0016	AMZ1 ARL14EP CASC10 MST1R PPA2
Trunk fat-free mass	7.46	5	3	6.7	0.90	0.0133	AMZ1 ARL14EP CASC10 MST1R PPA2
Trunk predicted mass	7.44	5	3	6.7	0.90	0.0137	AMZ1 ARL14EP CASC10 MST1R PPA2
Leg fat mass (left)	7.35	4	3	6.7	0.97	0.0064	AMZ1 ARL14EP CASC10 MST1R
Waist circumference	7.30	4	4	8.9	0.98	0.0039	AMZ1 ARL14EP CASC10 MST1R
Had other major operations	7.28	3	0	0.0	0.99	0.0134	ARL14EP CASC10 PPA2
Ulcerative Colitis (UC)	7.25	4	2	4.4	-0.42	0.5840	AMZ1 MST1R MTMR3 PPA2
Whole body fat mass	7.22	4	3	6.7	0.96	0.0087	AMZ1 ARL14EP CASC10 MST1R
Trunk fat mass	7.13	4	3	6.7	0.92	0.0278	AMZ1 ARL14EP CASC10 MST1R
Ulcerative Colitis	6.77	3	2	4.4	0.00	1.0000	AMZ1 MST1R PPA2
Arm fat mass (left)	6.53	4	3	6.7	0.96	0.0094	AMZ1 ARL14EP CASC10 MST1R
Intelligence (Savage-Jansen 2018)	6.41	2	2	4.4	0.00	1.0000	MST1R PPA2
Arm fat mass (right)	6.32	4	3	6.7	0.96	0.0089	AMZ1 ARL14EP CASC10 MST1R
Leg fat percentage (right)	6.23	3	2	4.4	0.97	0.0297	ARL14EP CASC10 MST1R
Bilateral oophorectomy (both ovaries removed)	6.21	3	0	0.0	1.00	0.0046	ARL14EP CASC10 MST1R
Leg fat percentage (left)	5.96	3	2	4.4	0.97	0.0284	ARL14EP CASC10 MST1R
Fluid intelligence score	5.94	2	2	4.4	0.00	1.0000	MST1R PPA2
Forced vital capacity (FVC), Best measure	5.88	5	3	6.7	0.50	0.3177	AMZ1 CASC10 MST1R MTMR3 PPA2
Forced expiratory volume in 1-second (FEV1), Best measure	5.85	3	1	2.2	0.66	0.3446	CASC10 MST1R PPA2
Body mass index (BMI)	5.82	3	2	4.4	0.94	0.0639	ARL14EP CASC10 MST1R
BMI	5.62	3	3	6.7	0.94	0.0557	ARL14EP CASC10 MST1R
Comparative height size at age 10	5.61	4	2	4.4	0.41	0.5875	AMZ1 MST1R MTMR3 PPA2
Ever had hysterectomy (womb removed)	5.58	3	0	0.0	0.00	1.0000	ARL14EP CASC10 MST1R
Qualifications: A levels/AS levels or equivalent	5.45	2	1	2.2	0.00	1.0000	MST1R PPA2
Irritable Bowel Disease (IBD)	5.27	3	3	6.7	0.00	1.0000	AMZ1 MST1R MTMR3
Lung FEV1/FVC ratio	5.17	4	2	4.4	0.42	0.4834	AMZ1 ARL14EP CASC10 PPA2
Forced vital capacity (FVC)	5.14	5	2	4.4	0.50	0.3112	AMZ1 CASC10 MST1R MTMR3 PPA2
Birth weight of first child	5.13	2	1	2.2	0.00	1.0000	AMZ1 PPA2
Birth weight	5.05	3	1	2.2	0.00	1.0000	AMZ1 PPA2 PPP6R2
Qualifications: None of the above	4.97	2	1	2.2	0.00	1.0000	MST1R PPA2
Ovarian Cancer	4.95	1	1	2.2	0.00	1.0000	CASC10
Body fat percentage	4.91	4	3	6.7	0.97	0.0064	AMZ1 ARL14EP CASC10 MST1R
Forced expiratory volume in 1-second (FEV1)	4.87	2	1	2.2	0.00	1.0000	MST1R PPA2
Age at first live birth	4.86	1	1	2.2	0.00	1.0000	MST1R
Age at First Birth	4.83	1	1	2.2	0.00	1.0000	MST1R
Verbal and Numeric Reasoning (VNR)	4.81	2	2	4.4	0.00	1.0000	MST1R PPA2
Trunk fat percentage	4.81	4	2	4.4	0.93	0.0221	AMZ1 ARL14EP CASC10 MST1R
Age at last live birth	4.77	1	1	2.2	0.00	1.0000	MST1R
Impedance of arm (left)	4.69	5	1	2.2	-0.58	0.2240	AMZ1 ARL14EP CASC10 MST1R PPA2
Forced expiratory volume in 1-second (FEV1), predicted percentage	4.58	3	1	2.2	0.00	1.0000	AMZ1 MST1R PPA2
Impedance of arm (right)	4.46	4	2	4.4	-0.55	0.3385	AMZ1 ARL14EP CASC10 MST1R
Arm fat percentage (left)	4.38	4	3	6.7	0.96	0.0107	AMZ1 ARL14EP CASC10 MST1R
Forced expiratory volume in 1-second (FEV1), predicted	4.36	2	1	2.2	0.00	1.0000	AMZ1 PPA2
Maternal smoking around birth	4.28	2	0	0.0	0.00	1.0000	CASC10 MST1R
Number of treatments/medications taken	4.14	2	0	0.0	0.00	1.0000	CASC10 MST1R
Ever had bowel cancer screening	4.13	2	0	0.0	0.00	1.0000	CASC10 MST1R
Arm fat percentage (right)	4.09	4	2	4.4	0.95	0.0140	AMZ1 ARL14EP CASC10 MST1R
Smoking Status	4.07	2	2	4.4	0.00	1.0000	CASC10 MST1R
Taking other prescription medications	4.02	1	1	2.2	0.00	1.0000	MST1R
Exposure to tobacco smoke at home	4.02	1	0	0.0	0.00	1.0000	MST1R
Breast cancer (self-reported)	4.02	1	0	0.0	0.00	1.0000	CASC10
Overall health rating	3.99	3	1	2.2	0.00	1.0000	AMZ1 CASC10 MST1R
Worry too long after embarrassment	3.87	2	0	0.0	0.00	1.0000	CASC10 PPA2
Stomach or abdominal pain in last month	3.84	1	0	0.0	0.00	1.0000	PPA2
Ever smoked	3.80	3	0	0.0	0.00	1.0000	MST1R PPA2 PPP6R2
Past tobacco smoking	3.79	2	0	0.0	0.00	1.0000	CASC10 MST1R
Impedance of whole body	3.73	4	1	2.2	-0.88	0.0474	ARL14EP CASC10 MST1R PPA2
Medication: Co-codamol	3.70	1	0	0.0	0.00	1.0000	MST1R
Commuting to job workplace: Walk	3.69	1	0	0.0	0.00	1.0000	MST1R
Alcohol intake versus 10 years previously	3.67	2	0	0.0	0.00	1.0000	CASC10 MST1R
Number of self-reported non-cancer illnesses	3.57	2	0	0.0	0.00	1.0000	ARL14EP CASC10
Chronic bronchitis/emphysema (mother)	3.55	2	0	0.0	0.00	1.0000	CASC10 MST1R
Commuting to job workplace: Car/motor vehicle	3.55	1	0	0.0	0.00	1.0000	MST1R
Pain experienced in last month	3.55	2	0	0.0	0.00	1.0000	CASC10 MST1R
Smoking status: Previous	3.52	2	0	0.0	0.00	1.0000	CASC10 MST1R
Qualifications: nursing, teaching	3.40	2	0	0.0	0.00	1.0000	MST1R PPA2
Commuting to job workplace: Public transport	3.37	1	0	0.0	0.00	1.0000	PPA2
Mouth/teeth dental problems: Bleeding gums	3.31	2	0	0.0	0.00	1.0000	MTMR3 PPA2
Prostate Cancer	3.30	2	0	0.0	0.00	1.0000	MST1R PPA2
Medication: Paracetamol	3.30	2	0	0.0	0.00	1.0000	CASC10 MST1R
Reaction Time	3.25	3	0	0.0	0.36	0.6417	AMZ1 CASC10 PPA2
Average weekly beer plus cider intake	3.25	1	1	2.2	0.00	1.0000	MST1R
Loneliness, isolation	3.22	2	0	0.0	0.00	1.0000	MST1R PPA2
Medication: Omeprazole	3.18	1	0	0.0	0.00	1.0000	MST1R
Medication: Paracetamol	3.18	2	0	0.0	0.00	1.0000	CASC10 MST1R
Ever highly irritable/argumentative for 2 days	3.17	1	0	0.0	0.00	1.0000	MST1R
Qualifications: CSEs or equivalent	3.13	1	0	0.0	0.00	1.0000	MST1R
Guilty feelings	3.12	2	0	0.0	0.00	1.0000	MST1R PPA2
Breast Cancer	3.06	1	1	2.2	0.00	1.0000	CASC10
Number of full brothers	3.03	1	0	0.0	0.00	1.0000	MST1R
Mean time to correctly identify matches	3.03	1	0	0.0	0.00	1.0000	PPA2
Age when periods started (menarche)	3.02	1	1	2.2	0.00	1.0000	MST1R
Other serious medical condition/disability diagnosed by doctor	2.97	1	0	0.0	0.00	1.0000	PPA2
Type 2 Diabetes (T2D) (2018)	2.94	2	0	0.0	0.00	1.0000	ARL14EP MST1R
Fractured/broken bones in last 5 years	2.92	1	0	0.0	0.00	1.0000	PPA2
Chronotype (morning person)	2.89	1	0	0.0	0.00	1.0000	MST1R
Wheeze or whistling in the chest in last year	2.89	2	0	0.0	0.00	1.0000	AMZ1 MST1R
Seen a psychiatrist for nerves, anxiety, tension or depression	2.88	1	0	0.0	0.00	1.0000	PPA2
Leg pain on walking	2.87	1	0	0.0	0.00	1.0000	MST1R
Miserableness	2.83	1	1	2.2	0.00	1.0000	MST1R
Knee pain experienced in last month	2.71	2	0	0.0	0.00	1.0000	AMZ1 MST1R
Irritability	2.71	2	0	0.0	0.00	1.0000	PPA2 PPP6R2
Shortness of breath walking on level ground	2.69	1	0	0.0	0.00	1.0000	CASC10
Lung FVC	2.68	5	1	2.2	-0.61	0.1985	AMZ1 ARL14EP CASC10 MST1R PPA2
Seen doctor (GP) for nerves, anxiety, tension or depression	2.67	1	0	0.0	0.00	1.0000	PPA2
Ever used hormone-replacement therapy (HRT)	2.64	1	0	0.0	0.00	1.0000	ARL14EP
Neuroticism score	2.64	2	0	0.0	0.00	1.0000	MST1R PPA2
Impedance of leg (left)	2.63	2	1	2.2	0.00	1.0000	MST1R PPA2
Neuroticism	2.56	1	0	0.0	0.00	1.0000	MST1R
Neuroticism (Nagel 2018)	2.55	3	0	0.0	0.00	1.0000	CASC10 MST1R PPA2
Sensitivity / hurt feelings	2.55	1	0	0.0	0.00	1.0000	PPA2
Exposure to tobacco smoke outside home	2.55	1	0	0.0	0.00	1.0000	MST1R
Mouth/teeth dental problems: Dentures	2.54	2	0	0.0	0.00	1.0000	MST1R MTMR3
Number of full sisters	2.53	1	0	0.0	0.00	1.0000	CASC10
Financial situation satisfaction	2.53	1	0	0.0	0.00	1.0000	MST1R
Qualifications: O levels/GCSEs or equivalent	2.51	1	0	0.0	0.00	1.0000	MST1R
Average weekly red wine intake	2.51	1	0	0.0	0.00	1.0000	CASC10
Medication for pain relief, constipation, heartburn	2.50	1	0	0.0	0.00	1.0000	CASC10
Depression (Nagel 2018)	2.45	1	0	0.0	0.00	1.0000	PPA2
Blood White Count	2.45	7	2	4.4	-0.16	0.6996	AMZ1 ARL14EP CASC10 MST1R MTMR3 PPA2 PPP6R2
Pain all over the body in last month	2.44	1	0	0.0	0.00	1.0000	MST1R
Depressed Affect (Nagel 2018)	2.39	1	1	2.2	0.00	1.0000	MST1R
Ever unenthusiastic/disinterested for a whole week	2.35	1	0	0.0	0.00	1.0000	MST1R
Blood Platelet Count	2.33	4	2	4.4	-0.33	0.6721	AMZ1 CASC10 MTMR3 PPP6R2
Crohns Disease (2012)	2.30	2	0	0.0	0.00	1.0000	MST1R MTMR3
Alcohol drinker status: Never	2.30	1	0	0.0	0.00	1.0000	MTMR3
Heart disease (mother)	2.23	1	0	0.0	0.00	1.0000	MTMR3
Ever depressed for a whole week	2.21	1	0	0.0	0.00	1.0000	MST1R
Number of live births	2.20	1	0	0.0	0.00	1.0000	MST1R
Impedance of leg (right)	2.18	2	1	2.2	0.00	1.0000	MST1R PPA2
Peak expiratory flow (PEF)	2.16	2	0	0.0	0.00	1.0000	CASC10 PPA2
Crohns Disease (2017)	2.13	2	0	0.0	0.00	1.0000	MST1R MTMR3
Asthma	2.13	2	0	0.0	0.00	1.0000	CASC10 MST1R
Frequency of tenseness / restlessness in last 2 weeks	2.09	1	0	0.0	0.00	1.0000	MST1R
Alcohol intake frequency.	2.03	1	0	0.0	0.00	1.0000	PPA2
Asthma (self-reported)	2.02	2	0	0.0	0.00	1.0000	CASC10 MST1R
Systolic blood pressure, automated reading	2.01	3	0	0.0	0.00	1.0000	CASC10 MST1R PPA2
Worrier / anxious feelings	2.00	1	0	0.0	0.00	1.0000	CASC10
Diabetes diagnosed by doctor	1.99	1	0	0.0	0.00	1.0000	ARL14EP
Reason for reducing amount of alcohol drunk: Health precaution	1.94	1	0	0.0	0.00	1.0000	PPA2
Mood swings	1.94	1	0	0.0	0.00	1.0000	MST1R
Diastolic blood pressure, automated reading	1.94	2	0	0.0	0.00	1.0000	CASC10 MST1R
Fed-up feelings	1.88	1	0	0.0	0.00	1.0000	MST1R
Number of children fathered	1.88	1	0	0.0	0.00	1.0000	MST1R
Medication: Metformin	1.87	1	0	0.0	0.00	1.0000	PPP6R2
Frequency of tiredness / lethargy in last 2 weeks	1.87	1	0	0.0	0.00	1.0000	AMZ1
Bipolar Disorder (2018)	1.86	1	0	0.0	0.00	1.0000	MST1R
Friendships satisfaction	1.86	1	0	0.0	0.00	1.0000	PPA2
Diabetes (mother)	1.78	1	0	0.0	0.00	1.0000	PPP6R2
Hand grip strength (right)	1.78	2	0	0.0	0.00	1.0000	AMZ1 CASC10
Worry (Nagel 2018)	1.76	1	0	0.0	0.00	1.0000	CASC10
Respiratory disease	1.75	1	0	0.0	0.00	1.0000	MST1R
Pulse rate	1.70	1	0	0.0	0.00	1.0000	ARL14EP
Relative age of first facial hair	1.67	1	0	0.0	0.00	1.0000	MST1R
Body Mass Index (BMI) (2010)	1.66	1	0	0.0	0.00	1.0000	MST1R
Hand grip strength (left)	1.62	2	0	0.0	0.00	1.0000	AMZ1 CASC10
Current tobacco smoking	1.62	1	0	0.0	0.00	1.0000	MST1R
Hypothyroidism (self reported)	1.57	1	0	0.0	0.00	1.0000	MTMR3
Vascular/heart problems diagnosed by doctor	1.57	2	0	0.0	0.00	1.0000	ARL14EP CASC10
Neck or shoulder pain in last month	1.50	1	0	0.0	0.00	1.0000	MST1R
Allergy	1.49	1	0	0.0	0.00	1.0000	AMZ1
Pulse wave reflection index	1.47	1	0	0.0	0.00	1.0000	MST1R
Allergy or Eczema	1.39	1	0	0.0	0.00	1.0000	AMZ1
Cardiovascular Disease	1.39	1	0	0.0	0.00	1.0000	ARL14EP
Comparative body size at age 10	1.38	2	0	0.0	0.00	1.0000	ARL14EP MST1R
Hypothyroidism/myxoedema (self-reported)	1.37	1	0	0.0	0.00	1.0000	MTMR3
Headache pain in last month	1.32	1	0	0.0	0.00	1.0000	AMZ1
Bipolar Disorder or Schizophrenia	1.30	1	0	0.0	0.00	1.0000	PPA2
Pack years of smoking	1.30	1	0	0.0	0.00	1.0000	ARL14EP
Hypertension (Self-reported)	1.29	2	0	0.0	0.00	1.0000	ARL14EP CASC10
Heel T-Score	1.27	3	1	2.2	0.00	1.0000	AMZ1 ARL14EP CASC10
Hayfever, allergic rhinitis or eczema	1.24	1	0	0.0	0.00	1.0000	AMZ1
High blood pressure	1.22	2	0	0.0	0.00	1.0000	ARL14EP CASC10
Systolic Blood Pressure	1.16	3	0	0.0	0.00	1.0000	CASC10 PPA2 PPP6R2
Pulse rate, automated reading	0.99	1	0	0.0	0.00	1.0000	ARL14EP
Schizophrenia (2014)	0.96	1	0	0.0	0.00	1.0000	ARL14EP
Medication: Levothyroxine sodium	0.94	1	0	0.0	0.00	1.0000	MTMR3
Blood Eosinophil Count	0.73	2	0	0.0	0.00	1.0000	AMZ1 MST1R
Waist Hip Ratio (WHR)	0.67	2	0	0.0	0.00	1.0000	ARL14EP CASC10
Blood Red Count	0.44	1	0	0.0	0.00	1.0000	ARL14EP
Hair Pigment	0.13	1	0	0.0	0.00	1.0000	MTMR3

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Uterus	0	0.000	1.7
GTEx	Adipose Visceral Omentum	0	0.000	1.6
GTEx	Artery Aorta	0	0.000	1.6
GTEx	Artery Coronary	0	0.000	1.6
GTEx	Brain Caudate basal ganglia	0	0.000	1.6
GTEx	Brain Cerebellum	1	0.050	1.6
GTEx	Brain Cortex	1	0.097	1.6
GTEx	Brain Frontal Cortex BA9	0	0.000	1.6
GTEx	Brain Putamen basal ganglia	0	0.000	1.6
GTEx	Breast Mammary Tissue	0	0.000	1.6
GTEx	Cells EBV-transformed lymphocytes	0	0.000	1.6
GTEx	Colon Sigmoid	1	0.068	1.6
GTEx	Colon Transverse	0	0.000	1.6
GTEx	Esophagus Gastroesophageal Junction	1	0.069	1.6
GTEx	Heart Atrial Appendage	1	0.063	1.6
GTEx	Ovary	1	0.110	1.6
GTEx	Pancreas	1	0.061	1.6
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.6
GTEx	Small Intestine Terminal Ileum	0	0.000	1.6
GTEx	Spleen	0	0.000	1.6
GTEx	Stomach	0	0.000	1.6
ROSMAP	Brain Pre-frontal Cortex	2	0.046	1.6
GTEx	Adipose Subcutaneous	0	0.000	1.5
GTEx	Adrenal Gland	0	0.000	1.5
GTEx	Artery Tibial	1	0.027	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.5
GTEx	Brain Hippocampus	0	0.000	1.5
GTEx	Brain Hypothalamus	0	0.000	1.5
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.5
GTEx	Breast Mammary Tissue (Female)	1	0.061	1.5
GTEx	Cells Transformed fibroblasts	0	0.000	1.5
GTEx	Esophagus Mucosa	1	0.030	1.5
GTEx	Esophagus Muscularis	1	0.031	1.5
GTEx	Heart Left Ventricle	0	0.000	1.5
GTEx	Lung	0	0.000	1.5
GTEx	Muscle Skeletal	0	0.000	1.5
GTEx	Nerve Tibial	1	0.023	1.5
GTEx	Pituitary	0	0.000	1.5
GTEx	Prostate	0	0.000	1.5
GTEx	Skin Sun Exposed Lower leg	1	0.027	1.5
GTEx	Testis	0	0.000	1.5
GTEx	Thyroid	1	0.025	1.5
GTEx	Vagina	0	0.000	1.5
GTEx	Whole Blood	0	0.000	1.5
CommonMind	Brain Pre-frontal Cortex	1	0.019	1.5
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	1.5
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.5
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.5
GTEx	Liver	0	0.000	1.4
METSIM	Adipose	0	0.000	1.4
NTR	Blood	1	0.042	1.4
YFS	Blood	0	0.000	1.4
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Breast Invasive Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Brain Lower Grade Glioma	0	0.000	1.4
The Cancer Genome Atlas	Lung Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Prostate Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.4
The Cancer Genome Atlas	Stomach Adenocarcinoma	1	0.059	1.4
The Cancer Genome Atlas	Thyroid Carcinoma	1	0.019	1.4
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.2